Study S002646

Investigation of the Effects of Breakfast or Caffeine Containing Beverages on the Measurement of Plasma Chromogranin A in Patients With Gastro-entero-pancreatic Neuroendocrine Tumours (GEP-NET)

ClinicalTrials.gov record

Registration

Registration: NCT03288402
Acronym: DIB-NET
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 346
Start: 2017-02-01
Primary completion: 2021-08-10
Lead sponsor: University Hospitals Coventry and Warwickshire NHS Trust
Conditions: Neuroendocrine Tumors
Interventions: OTHER:ongoing fasted state, intake of caffeine containing beverages or 5-item English breakfast
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

changes in plasma CgA measurements related to intake of food or caffeine containing beverages, as compared to ongoing fasted state [up to 180 min]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.